Tag: Ciphergen Biosystems

ciphergen biosystems

Toronto Medical Has Acquired Ciphergen’s Autobiomarker Proteinchip System

Ciphergen Biosystems, Inc. has announced that Toronto Medical Laboratories (TML) has acquired Ciphergen’s AutoBiomarker ProteinChip System, with an objective of pursuing targeted assay development projects aimed at identifying new protein biomarkers that can be converted into commercial diagnostic tests as part of the TML reference lab business strategy. Ciphergen has granted TML, in conjunction with Read more about Toronto Medical Has Acquired Ciphergen’s Autobiomarker Proteinchip System[…]

pfizer

Ciphergen Enters Collaboration With Pfizer

Ciphergen Biosystems, Inc. has entered into a collaboration with Pfizer Inc. designed to discover proteins in serum from rat models as well as to evaluate the relative importance and utility of such proteins as biomarkers associated with drug safety. “This innovative predictive toxicology study will be carried out through our Biomarker Centers,” commented William Rich, Read more about Ciphergen Enters Collaboration With Pfizer[…]